Lamotrigine in the treatment of painful diabetic neuropathy

European Journal of Neurology

Volumn 5, Issue 2, 1998, Pages 167-173

  Eisenberg, E ^a,c   Alon, N ^a   Ishay, A ^b   Daoud, D ^a   Yarnitsky, D ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b HAEMEK MEDICAL CENTER   (Israel)

^c RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Allodynia; Glutamate; Hyperalgesia; Hyperexcitability; Neuropathic pain

Indexed keywords

ANTICONVULSIVE AGENT; GLUTAMIC ACID; LAMOTRIGINE; SODIUM CHANNEL;

ADULT; AGED; ALLODYNIA; ARTICLE; ATAXIA; CLINICAL ARTICLE; DIABETIC NEUROPATHY; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; MALE; PAIN; PRIORITY JOURNAL; QUESTIONNAIRE; RASH; RATING SCALE; VERTIGO;

EID: 0031888976     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1331.1998.520167.x     Document Type: Article

References (29)

1. Ahlgren SC, Levine JD (1993). Mechanical hyperalgesia in streptozotocin-diabetic rats. Neuroscience 52:1049-1055.
2. Boas RA (1996). Complex regional pain syndromes: symptoms, signs, and differential diagnosis. In: Reflex sympathetic dystrophy: a reappraisal. Janig W, Stanton-Hicks M (editors). Seattle, WA: IASP. pp. 79-92.
3. Brown MJ and Asbury AK (1984). Diabetic neuropathy. Ann Neurol 15:2-12.
4. Burchiel KJ, Russell LC, Lee RC, Sima AFF (1985). Spontaneous activity of primary afferent neurons in diabetic BB/ Wistar rats. Diabetes 34:1210-1213.
5. Cheung H, Kamp D, Harris E (1992). An in vitro investigation of the action of Iamotrigine on neural voltage-activated sodium channels. Epilepsy Res 13:107-112.
6. Cline M, Ochoa J, Torebjork HE (1989). Chronic hyperalgesia and skin warming caused by sensitized C nociceptors. Brain 112:621-647.
7. Dahl JB, Brennum J, Arednt-Nielsen L, Jensen TS, Kehlet H (1993). The effect of pre- versus post-injury infiltration with lidocaine on thermal and mechanical hyperalgesia after heat injury to the skin. Pain 53:43-51.
8. Davar G, Waikar S, Eisenberg E, Thalhammer HJ, Hattori M (1995). Short latencies to hindpaw withdrawal from a thermal stimulus in the non-obese diabetic mouse. Neurosci Lett 190:171-174.
9. + channel blockers in neuropathic pain. Pain Forum 4:83-86.
10. Dickenson AH, Sullivan AF (1987). Evidence for a role of the NMDA receptor in frequency dependent potentiation of deep dorsal horn neurons following c-fiber stimulation. Neuropharmacology 26:1235-1238.
11. Dubner R, Ruda MA (1992). Activity dependent neural plasticity following tissue injury and inflammation. Trends Neurosci 14:96-103.
12. Eide PK, Stubhaug A, Oye I, Breivik H (1995). Continuous subcutaneous administration of the N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgia. Pain 61:221-228.
13. Fields HL (1994). Peripheral neuropathic pain: an approach to management. In: Textbook of pain. 3rd ed. Wall PD, Melzack R (editors). Churchill Livingstone, Edinburgh, pp. 219-227.
14. Frost SA, Raja SN, Campbell JN, Mayer RA, Khan AA (1988). Does hyperalgesia to cooling stimuli characterize patients with sympathetically maintained pain (reflex sympathetic dystrophy)? In: Proceedings of the Vth world congress of pain. Dubner R, Gebhart GF, Bond MR (editors). Amsterdam: Elsevier. pp. 151-156.
15. Goa KL, Ross SR, Chrisp P (1993). Lamotrigine. A review of its pharmacological properties and clinical efficacy in epilepsy. Drugs 46:152-176.
16. Jensen MP, Karoly P (1992). Self-report scales and procedures for assessing pain in adults. In: Handbook of pain assessment. Turk DC, Melzack R (editors). Guilford Press, New York, pp. 131-151.
17. Laired JMA, Bennett GJ (1993). An electrophysiological study of dorsal horn neurons in the spinal cord of rats with an experimental peripheral neuropathy. J Neurophysiol 69:2072-2085.
18. Lee JH, Cox DJ, Mook DJ, McCarty RC (1990). Effect of hyperglycemia on pain threshold in alloxan-diabetic rats. Pain 40:105-107.
19. Loeser JD (1986). Herpes zoster and postherpetic neuralgia. Pain 25:149-164.
20. Makamura-Craig M, Follenfant RL (1994). Lamotrigine and analogs: a new treatment for chronic pain? In: Proceedings of the 7th World Congress on Pain, Progress in Pain Research. Gebhart GF, Hammond DL, Jensen TL (editors). Seattle, WA: IASP. pp. 725-730.
21. Makamura-Craig M, Follenfant RL (1995). Effect of lamotrigine in the acute and chronic hyperalgesia induced by PGE2 and in the chronic hyperalgesia in rats with streptozotocin-induced diabetes. Pain 63:33-37.
22. Melzack R (1975). The McGill pain questionnaire. Pain 1:272-299.
23. Navarro X, Kennedy WR (1991). Evaluation of thermal and pain sensitivity in type I diabetic patients. Journal of Neurology, Neurosurgery and Psychiatry 54:60-64.
24. Peterson DW, Collins JF, Bradford HF (1983). Transmitter amino acids and their antagonists in epilepsy. In: Glutamine, glutamate and GABA in the central nervous system, New York: Alan R Liss. pp. 643-653.
25. Price DD, MeGrath PA, Rafii A, Buckingham B (1983). The validation of the visual analogue scale as ratio scale measures for chronic and experimental pain. Pain 17:45-46.
26. Smith D, Baker, G, Davies G, Dewey M, Chadwick DW (1993). Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia 34:312-322.
27. Thomas PK, Tomlinson DR (1993). Diabetic and hypoglycemic neuropathy. In: Peripheral neuropathy. 3rd ed. Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF (editors). Philadelphia, PA: WB Saunders. pp. 1219-1250.
28. Watson CPN, Evans RJ, Watt VR, Birkett N (1988). Postherpetic neuralgia: 208 cases. Pain 35:289-297.
29. Yarnitsky D, Fowler C (1995). Quantitative thermal testing. In: Clinical Neurophysiology. Osselton JW (editor). Oxford: Butterworth-Heinemann. pp. 253-270.